HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Damien M Cronier Selected Research

Drug Therapy (Chemotherapy)

1/2018Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer.
7/2016Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Damien M Cronier Research Topics

Disease

6Neoplasms (Cancer)
01/2018 - 06/2014
5Sarcoma (Soft Tissue Sarcoma)
01/2020 - 07/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 01/2016
2Disease Progression
01/2019 - 01/2017
2Glioblastoma (Glioblastoma Multiforme)
01/2018 - 01/2016
2Multiple Myeloma
03/2017 - 12/2016
2Melanoma (Melanoma, Malignant)
03/2016 - 01/2016
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015 - 03/2012
1Body Weight (Weight, Body)
01/2018
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1Neutropenia
07/2016
1Nausea
07/2016
1Vomiting
07/2016
1Mucositis
07/2016
1Febrile Neutropenia
07/2016
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Leukemia
06/2014
1Fatigue
03/2012
1Chills
03/2012

Drug/Important Bio-Agent (IBA)

5olaratumabIBA
01/2020 - 07/2016
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 07/2016
4abemaciclibIBA
01/2018 - 07/2014
3Monoclonal AntibodiesIBA
01/2018 - 01/2015
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2018 - 01/2016
2B-Cell Activating FactorIBA
03/2017 - 12/2016
2Bortezomib (Velcade)FDA Link
03/2017 - 12/2016
2tabalumabIBA
03/2017 - 12/2016
2Biomarkers (Surrogate Marker)IBA
03/2016 - 07/2014
2ocaratuzumabIBA
01/2015 - 03/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2017
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2017
1AnthracyclinesIBA
07/2016
1Growth Factor ReceptorsIBA
07/2016
1VemurafenibIBA
03/2016
1Hormones (Hormone)IBA
01/2016
1Cyclin-Dependent Kinase 4IBA
07/2014
1Cytostatic AgentsIBA
07/2014
1N1- (4- (3- isopropyl- 2- methylindazol- 5- yl)pyrimidin- 2- yl)- N4- tetrahydropyran- 4- yl- cyclohexane- 1,4- diamineIBA
06/2014
1Proteins (Proteins, Gene)FDA Link
06/2014
1Phosphotransferases (Kinase)IBA
06/2014

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2018 - 07/2016
1Intravenous Administration
01/2020